Clinical studies recruiting near Aiea

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Effective Phaco Time and Endothelial Cell Loss When Using Veritas
Phase N/A · Aloha Vision Consultants · Aloha Vision Consultants · NCT07176416 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Hawaii Cancer Care - Westridge · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Hawaii Cancer Care - Westridge · NRG Oncology · NCT05624996 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Hawaii Cancer Care - Westridge · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Hawaii Cancer Care - Westridge · NRG Oncology · NCT05174169 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Hawaii Cancer Care - Westridge · Canadian Cancer Trials Group · NCT06592924 SELUTION 4 De Novo Small Vessel IDE Trial
NA · Pali Momi Medical Center · M.A. Med Alliance S.A. · NCT05946629 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Hawaii Cancer Care - Westridge · National Cancer Institute (NCI) · NCT06498635 Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degen
Phase 2 · Adverum site 149 · Adverum Biotechnologies, Inc. · NCT07630649 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Hawaii Cancer Care - Westridge · NRG Oncology · NCT04852887 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Hawaii Cancer Care - Westridge · Alliance for Clinical Trials in Oncology · NCT05677490 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · Cardiology Associates, Inc · Pfizer · NCT06989437 An Internet-based Program to Help Cancer Survivors Manage Pain
NA · Hawaii Cancer Care - Savio · Wake Forest University Health Sciences · NCT04462302 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Pali Momi Medical Center · NRG Oncology · NCT05080673 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Hawaii Cancer Care - Westridge · National Cancer Institute (NCI) · NCT05564377 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · Hawaii Cancer Care - Westridge · National Cancer Institute (NCI) · NCT06317649 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Hawaii Cancer Care - Westridge · ECOG-ACRIN Cancer Research Group · NCT02734537 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Pali Momi Medical Center · SWOG Cancer Research Network · NCT03418961 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Hawaii Cancer Care - Westridge · SWOG Cancer Research Network · NCT03723928 BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · Hawaii Cancer Care - Westridge · National Cancer Institute (NCI) · NCT05136196 Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Phase 3 · Hawaii Cancer Care - Westridge · University of Rochester · NCT05006482 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Hawaii Cancer Care - Westridge · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Hawaii Cancer Care - Westridge · SWOG Cancer Research Network · NCT03851445 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Hawaii Cancer Care - Westridge · NRG Oncology · NCT04251052 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Hawaii Cancer Care - Westridge · NRG Oncology · NCT06580314 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Hawaii Cancer Care - Westridge · SWOG Cancer Research Network · NCT05642572 Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · Hawaii Cancer Care - Westridge · National Cancer Institute (NCI) · NCT04181060 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · Hawaii Cancer Care - Westridge · Alliance for Clinical Trials in Oncology · NCT05812807 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-M
Phase 2 · Hawaii Cancer Care - Westridge · SWOG Cancer Research Network · NCT06116682 Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colore
Phase 3 · Hawaii Cancer Care - Westridge · SWOG Cancer Research Network · NCT07018869

Look up another city

Look up another condition